Research updates from Luvaminos
Subscribe for catalog updates, new research compounds, and quality documentation releases.
For researchers and labs. No spam — unsubscribe anytime.
For Research Purposes Only
Out of StockBPC-157 / TB-500 / KPV
Third-Party TestedPurity Standards
Total
$89.99Size
Quantity
1
Bundle & Save
Molecular Profile
Molecular Profile
Peptide blend
BPC-157
Molecular formula
C62H98N16O22
Molecular weight
1,419.5 g/mol
CAS number
137525-51-0
Sequence
GEPPPGKPADDAGLV
TB-500 (full-length acetylated Thymosin Beta-4)
Molecular formula
C212H350N56O78S
Molecular weight
~4,963 g/mol
CAS number
77591-33-4
Sequence
Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES
KPV
Molecular formula
C16H30N4O4
Molecular weight
342.43 g/mol
CAS number
67727-97-3
Sequence
Lys-Pro-Val
Mechanism & Target Class
Mechanism & Target Class
A three-component formulation combining a gastric-juice-derived pentadecapeptide (BPC-157), a full-length Thymosin Beta-4-related actin-binding peptide (TB-500), and an alpha-MSH-derived tripeptide (KPV). The components are associated in the literature with distinct molecular contexts — VEGFR2/eNOS-related vascular signaling, intracellular G-actin sequestration, and PepT1 transport with NF-kB / MAPK signaling, respectively — and the blend has no single shared target.
Storage & Handling
Storage & Handling
Lyophilized
20°C
protect from light; stable months desiccated.
Multi-peptide blend; component ratios vary by supplier; aliquot to avoid freeze-thaw.
References
References
Reviews
- 1
Vasireddi N, et al. (2025). HSS Journal
- 2
Jozwiak M, et al. (2025). Pharmaceuticals (Basel)
Reviews
- 3
Narrative review (2025). Curr Rev Musculoskelet Med
- 4
Kleinman HK, Sosne G. (2016). Vitam Horm
- 5
Sikiric P, et al. (2014). Curr Pharm Des
- 6
Goldstein AL, et al. (2012). Expert Opin Biol Ther
- 7
Sikiric P, et al. (2011). Curr Pharm Des
- 8
Brzoska T, et al. (2010). Adv Exp Med Biol
- 9
Brzoska T, et al. (2008). Endocr Rev
- 10
Huff T, et al. (2003). Vitam Horm
Clinical
- 11
ClinicalTrials.gov. ClinicalTrials.gov
- 12
ClinicalTrials.gov. ClinicalTrials.gov
- 13
ClinicalTrials.gov. ClinicalTrials.gov
- 14
ClinicalTrials.gov. ClinicalTrials.gov
- 15
ClinicalTrials.gov. ClinicalTrials.gov
Primary research
- 16
He L, et al. (2022). Front Pharmacol
- 17
Hsieh MJ, et al. (2020). Sci Rep
- 18
Xiao B, et al. (2017). Mol Ther
- 19
Hsieh MJ, et al. (2017). J Mol Med (Berlin)
- 20
Cox HD, et al. (2017). Drug Test Anal
- 21
Merlin D, et al. (2016). Cell Mol Gastroenterol Hepatol
- 22
Chang CH, et al. (2014). Molecules
- 23
Xue B, et al. (2014). PNAS
- 24
Chang CH, et al. (2011). J Appl Physiol
- 25
Kumar S, Gupta S. (2011). PLoS One
- 26
Dalmasso G, et al. (2008). Gastroenterology
- 27
Kannengiesser K, et al. (2008). Inflamm Bowel Dis
- 28
Smart N, et al. (2007). Nature
- 29
Bock-Marquette I, et al. (2004). Nature
Research Use Only. All products sold by Luvaminos are intended solely for in vitro research and laboratory use by qualified professionals. They are not approved by the FDA and are not intended for human or animal consumption, therapeutic use, or diagnostic purposes. By purchasing, you confirm you are a licensed researcher or institution and accept full responsibility for compliance with all applicable laws and regulations.
